Skip to main content

Table 7 Risk factor of hematogenous metastasis in patients with stage III disease

From: Appraisal of long-time outcomes after curative surgery in elderly patients with gastric cancer: a propensity score matching analysis

  Hematogenous metastasis p value
Present (n = 8) Absent (n = 40)
Depth of tumor invasion 0.600
 T2/3 4 (50.0) 24 (60.0)  
 T4 4 (50.0) 16 (40.0)  
Lymph node metastasis 0.897
 N1/2 4 (50.0) 21 (52.5)  
 N3 4 (50.0) 19 (47.5)  
Histologic type 0.273
 Differentiated 4 (50.0) 12 (30.0)  
 Undifferenciated 4 (50.0) 28 (70.0)  
Lymphatic invasion 1.000
ly0/1/2 5 (62.5) 25 (62.5)  
 ly3 3 (37.5) 15 (37.5)  
Venous invasion 0.439
 v0/1 3 (37.5) 21 (52.5)  
 v2/3 5 (62.5) 19 (47.5)  
Lymphadectomy 0.055
  < D2 5 (62.5) 11 (27.5)  
 D2 3 (37.5) 29 (72.5)  
Adjuvant chemotherapy 0.242
 Present 3 (37.5) 24 (60.0)  
 Absent 5 (62.5) 16 (40.0)  
  1. Data are presented as number (percentage) of patients